α2-Macroglobulin: A novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers

American Journal of Pathology

Volumn 165, Issue 5, 2004, Pages 1479-1488

  Sukata, Tokuo ^a,b   Uwagawa, Satoshi ^a,b   Ozaki, Keisuke ^a,b   Sumida, Kayo ^a   Kikuchi, Kaoru ^c   Kushida, Masahiko ^a,b   Saito, Koichi ^a   Morimura, Keiichirou ^b   Oeda, Kenji ^a   Okuno, Yasuyoshi ^a   Mikami, Nobuyoshi ^a   Fukushima, Shoji ^b  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; CLOFIBRATE; DIETHYLNITROSAMINE; MESSENGER RNA; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; DNA MICROARRAY; GENE EXPRESSION; IN SITU HYBRIDIZATION; LASER MICRODISSECTION; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER INJURY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 7244242265     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63406-2     Document Type: Article

References (43)

1. Ito N, Hananouchi M, Sugihara S, Shirai T, Tsuda H, Fukushima S, Nagasaki H: Reversibility and irreversibility of liver tumors in mice induced by the α isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res 1976, 36:2227-2234
2. Moore MA, Hacker H-J, Bannasch P: Phenotypic instability in focal and nodular lesions induced in a short-term system in the rat liver. Carcinogenesis 1983, 4:595-603
3. Tatematsu M, Nagamine Y, Farber E: Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res 1983, 43:5049-5058
4. Takahashi S, Lombardi B, Shinozuka H: Progression of carcinogen-induced foci of gamma-glutamyltranspeptidase-positive hepatocytes to hepatomas in rats fed a choline-deficient diet. Int J Cancer 1982, 29:445-450
5. Scherer E, Emmelot P: Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat. Eur J Cancer 1975, 11:689-696
6. Moore MA, Mayer D, Bannasch P: The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 1982, 3:1429-1436
7. Ogawa K, Solt DB, Farber E: Phenotypic diversity as an early property of putative preneoplastic hepatocyte populations in liver carcinogenesis. Cancer Res 1980, 40:725-733
8. Enomoto K, Farber E: Kinetics of phenotypic maturation of remodelling of hyperplastic nodules during liver carcinogenesis. Cancer Res 1982, 42:2330-2335
9. Sotl DB, Medline A, Farber E: Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 1977, 88:595-618
10. Ito N, Tsuda H, Hasegawa R, Imaida K: Sequential observation of pathomorphologic alterations in preneoplastic lesions during the promotion stage of hepatocarcinogenesis and the development of a short-term test system for hepatopromoters and hepatocarcinogens. Toxicol Pathol 1982, 10:37-49
11. Tatematsu M, Kaku T, Medline A, Frikson L, Roomi W, Sharma RN, Murray RK, Farber E: Markers of liver neoplasm - real or fictional? Application of Biological Markers to Carcinogen Testing. Edited by H Milman, S Sell. New York, Plenum, 1983, pp 25-42
12. Sato K, Kitahara A, Satoh K, Ichikawa T, Tatematsu M, Ito N: The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical carcinogenesis. Gann 1984, 75:199-202
13. Ito N, Tsuda H, Tatematsu M, Inoue T, Tagawa Y, Aoki T, Uwagawa S, Kagawa M, Ogiso T, Masui T, Imaida K, Fukushima S, Asamoto M: Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 1988, 9:387-394
14. Rao MS, Tatematsu M, Subbarao V, Ito N, Reddy JK: Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase. Cancer Res 1986, 46:5287-5290
15. Rao MS, Nemali MR, Usuda N, Scarpelli DG, Makino T, Pitot HC, Reddy JK: Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res 1988, 48:4919-4925
16. Weber E, Moore MA, Bannasch P: Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis 1988, 9:1049-1054
17. Mayer D, Metzger C, Loenetti P, Beier K, Benner A, Bannasch P: Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer 1998, 79:232-240
18. Schreiber G, Howlett G, Nagashima M, Millership A, Martin H, Urban J, Kotler L: The acute phase response of plasma protein synthesis during experimental inflammation. J Biol Chem 1982, 257:10271-10277
19. Northemann W, Andus T, Gross V, Nagashima M, Schreiber G, Heinrich PC: Messenger RNA activities of four acute phase proteins during inflammation. FEBS Lett 1983, 161:319-322
20. 2- macroglobulin with proteinase. Biochem J 1973, 133:709-724
21. 2- macroglobulin. Immunol Today 1990, 11:163-166
22. 2-macroglobulin: implication for the study of peptide and growth factor binding. Biochemistry 1991, 30:1551-1560
23. 2- Macroglobulin is a binding protein for basic fibroblast growth factor. J Biol Chem 1989, 264:7210-7216
24. O'Conner-McCourt MD, Wakefield LM: Latent transforming growth factor-β in serum. J Biol Chem 1987, 262:14090-14099
25. 2- macroglobulin. Proc Natl Acad Sci USA 1984, 81:342-346
26. 2-macroglobuiln complex is a latent form of transforming growth factor β. J Biol Chem 1988, 263:1535-1541
27. Kar P, Gandhi BM, Irshad M, Gupta H, Tandon BN: Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma. J Assoc Physicians India 1987, 35:288-289
28. Poon TC, Chan AT, Zee B, Ho SK, Mok TS, Leung TW, Johnson PJ: Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology 2001, 61:275-283
29. Kotaka M, Chen GG, Lai PB, Lau WY, Chan PK, Leung TW, Li AK: Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization. Oncol Res 2002, 13:161-167
30. Beaton GH, Selby AE, Veen MJ, Wright AM: Starch gel electrophoresis of rat serum proteins. II. Slow alpha 2-globulin and other serum proteins in pregnant, tumor bearing, and young rats. J Biol Chem 1961, 236:2005-2008
31. Stanislawski-Birencwajg M, Uriel J, Grabar P: Association of embryonic antigens with experimentally induced hepatic lesions in the rat. Cancer Res 1967, 27:1990-1997
32. Hudig D, Sell S, Newell L, Becker FF: Rat alpha-macrofetoprotein (acute-phase alpha 2-macroglobulin) during hepatocarcinogenesis. Cancer Res 1979, 39:3715-3719
33. Hasegawa R, Yoshida T, Mizoguchi Y, Futakuchi M, Kim DJ, Cui L, Ito N: Phenotypic alteration of hepatocellular foci in rats treated with clofibrate and phenobarbital. Cancer Lett 1994, 83:89-95
34. Jones TC, Mohr U, Hunt RD (Eds): Monographs on Pathology of Laboratory Animals Sponsored by the International Life Sciences Institute, Digestive System. Berlin, Springer, 1997, pp 3-37
35. Smorenburg SM, Griffini P, Tiggelman AB, Moorman AF, Boers W, Van Noorden JF: Alpha2-macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver. Hepatology 1996, 23:560-570
36. Strange J, Roberts RA: Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Mutat Res 1996, 372:107-113
37. Wollenberg GK, LaMarre J, Semple E, Farber E, Gauldie J, Hayes MA: Counteracting effects of dexamethasone and alpha 2-macroglobulin on inhibition of proliferation of normal and neoplastic rat hepatocytes by transforming growth factors-beta type 1 and type 2. Int J Cancer 1991, 47:311-316
38. West DA, James NH, Cosulich SC, Holden PR, Brindle R, Rolfe M, Roberts RA: Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin. Hepatology 1999, 30:1417-1424
39. Dolezalova V, Stratil P, Simickova M, Kocent A, Nemecek R: Alpha-fetoprotein (AFP) and alpha 2-macroglobulln (alpha 2-M) as the markers of distinct responses of hepatocytes to carcinogens in the rat: carcinogenesis. Ann NY Acad Sci 1983, 417:294-307
40. Katerinaki E, Evans GS, Lorigan PC, MacNeil S: TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer 2003, 89:1123-1129
41. Ito H, Miyazaki M, Nishimura F, Nakajima N: Secretion of extracellular matrix (fibronectin), growth factor (transforming growth factor beta) and protease (cathepsin D) by hepatoma cells. Oncology 2000, 58:261-270
42. Asplin IR, Misra UK, Gawdi G, Gonzalez-Gronow M, Pizzo SV: Selective upregulated expression of the alpha2-macroglobulin signaling receptor in highly metastatic 1-LN prostate carcinoma cells. Arch Biochem Biophys 2000, 383:135-141
43. Strickland DK, Kounnas MZ, Argraves WS: LDL-receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995, 9:890-898